Peng Zhang, MD 1,2 , Wen-Yuan Li, MD 1 , Shi-Cheng Yang, MD 2 , Nai-Kuan Fu, MD 2 , Xiao-Gang Liu, MD 2 , Xue Zhang, MD 1 , Hong-Liang Cong, MD 2 , Wen-Hua Lin, MD 3 , Feng-Shi Tian, MD 4 , Cheng-Zhi Lu, MD 5 , and Jing Zhang, MD 2 Karanfil et al 1 comment on our article entitled "Preventive effects of nicorandil against contrast induced nephropathy in patients with moderate renal insufficiency undergoing percutaneous coronary intervention." 2 As described by Karanfil et al, 1 metformin has an adverse effect in the diabetic population after contrast agent exposure. 3 Patients with contrast-induced nephropathy (CIN) are at increased risk of long-term loss of renal function, cardiovascular events, and death, 4 as also highlighted by a Chinese expert consensus. 5 For patients with normal renal function, metformin should not be discontinued before angiography but should be discontinued for 2 to 3 days under the guidance of the physician after using contrast agent 5 ; for patients with abnormal renal function, metformin should be temporarily discontinued 2 days before the use of contrast medium and then restarted 2 to 3 days after the use of contrast medium. 5 For uniformity in our study, 2 patients on daily metformin stopped the drug 3 days before percutaneous coronary intervention and restarted it again 3 days after the use of contrast medium if they did not have CIN. If they had CIN, patients needed to discontinue metformin and switch to other hypoglycemic drugs and transfer to nephrology for further treatment if necessary. We observed no difference in CIN incidence between metformin users and those who did not take metformin. 2 Trimetazidine was not used in our patients. 2 Furthermore, there was no significant difference in random blood glucose levels between the nicorandil and control groups in patients with diabetes (11.1 + 2.1 vs 11.4 + 1.8 mmol/L, P > .05). 2 
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